{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T21:20:17Z","timestamp":1787779217212,"version":"build-2784847793"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018617","name":"Liaoning Revitalization Talents Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018617","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.biomaterials.2026.124449","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:20:52Z","timestamp":1783725652000},"page":"124449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oncolytic virus-drug conjugates for increased viral replication efficiency and potentiated cancer chemoimmunotherapy"],"prefix":"10.1016","volume":"336","author":[{"given":"Tao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyue","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengda","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenguo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Funan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7494-3963","authenticated-orcid":false,"given":"Jin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124449_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abn2231","article-title":"Oncolytic virus-mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice","volume":"14","author":"Evgin","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124449_bib2","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1038\/s41467-021-22929-z","article-title":"Adjuvant oncolytic virotherapy for personalized anti-cancer vaccination","volume":"12","author":"Roy","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124449_bib3","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1038\/s41596-024-00985-1","article-title":"Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy","volume":"19","author":"Gujar","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2026.124449_bib4","article-title":"Intravenous infusion of engineered megakaryocytes to produce oncolytic platelets in vivo for enhanced cancer immunotherapy","volume":"123","author":"Yang","year":"2026","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.biomaterials.2026.124449_bib5","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1038\/s41467-020-17011-z","article-title":"Oncolytic virus-derived type I interferon restricts CAR T cell therapy","volume":"11","author":"Evgin","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124449_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrurol.2018.10","article-title":"Potentiating prostate cancer immunotherapy with oncolytic viruses","volume":"15","author":"Lee","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.biomaterials.2026.124449_bib7","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.abk3436","article-title":"Oncolytic virotherapy as immunotherapy","volume":"374","author":"Melcher","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2026.124449_bib8","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1007\/s12274-021-4031-6","article-title":"Emerging systemic delivery strategies of oncolytic viruses: a key step toward cancer immunotherapy","volume":"15","author":"Ban","year":"2022","journal-title":"Nano Res."},{"key":"10.1016\/j.biomaterials.2026.124449_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nrd4663","article-title":"Oncolytic viruses: a new class of immunotherapy drugs","volume":"14","author":"Kaufman","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124449_bib10","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.immuni.2019.07.003","article-title":"Oncolytic viruses engineered to enforce leptin expression reprogram tumor-infiltrating T cell metabolism and promote tumor clearance","volume":"51","author":"Rivadeneira","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2026.124449_bib11","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1038\/s41467-022-29526-8","article-title":"Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy","volume":"13","author":"Wedge","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124449_bib12","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41587-023-01796-7","article-title":"An engineered influenza virus to deliver antigens for lung cancer vaccination","volume":"42","author":"Ji","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biomaterials.2026.124449_bib13","doi-asserted-by":"crossref","first-page":"7267","DOI":"10.1038\/s41467-024-51498-0","article-title":"Complementary dual-virus strategy drives synthetic target and cognate T-cell engager expression for endogenous-antigen agnostic immunotherapy","volume":"15","author":"Taha","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124449_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101345","article-title":"Overcoming resistance in oncolytic virotherapy: nano-engineered solutions for systemic delivery and efficacy boost","volume":"85","author":"Wang","year":"2026","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.biomaterials.2026.124449_bib15","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41467-020-15229-5","article-title":"An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124449_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41392-022-00951-x","article-title":"Engineering strategies to enhance oncolytic viruses in cancer immunotherapy","volume":"7","author":"Tian","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.biomaterials.2026.124449_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-020-01275-6","article-title":"Improving antitumor efficacy via combinatorial regimens of oncolytic virotherapy","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124449_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2018.12.022","article-title":"Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice","volume":"294","author":"Garofalo","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124449_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202209379","article-title":"A dual-responsive STAT3 inhibitor nanoprodrug combined with oncolytic virus elicits synergistic antitumor immune responses by igniting pyroptosis","volume":"35","author":"Su","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124449_bib20","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1021\/acsnano.3c09491","article-title":"Synergistic viro-chemoimmunotherapy in breast cancer enabled by bioengineered immunostimulatory exosomes and dual-targeted coxsackievirus B3","volume":"18","author":"Bahreyni","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124449_bib21","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-023-02309-4","article-title":"Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial","volume":"29","author":"Soliman","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2026.124449_bib22","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1470-2045(24)00079-2","article-title":"LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1\/2 study","volume":"25","author":"Musher","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.biomaterials.2026.124449_bib23","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1038\/s41467-023-38679-z","article-title":"Engineered bacterial outer membrane vesicles encapsulating oncolytic adenoviruses enhance the efficacy of cancer virotherapy by augmenting tumor cell autophagy","volume":"14","author":"Ban","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124449_bib24","doi-asserted-by":"crossref","first-page":"8318","DOI":"10.1021\/acs.nanolett.9b03968","article-title":"Aggregable nanoparticles-enabled chemotherapy and autophagy inhibition combined with Anti-PD-L1 antibody for improved glioma treatment","volume":"19","author":"Ruan","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2026.124449_bib25","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.actbio.2019.01.020","article-title":"Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy","volume":"86","author":"Li","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biomaterials.2026.124449_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s13058-022-01599-9","article-title":"MTX-PEG-modified CG\/DMMA polymeric micelles for targeted delivery of doxorubicin to induce synergistic autophagic death against triple-negative breast cancer","volume":"25","author":"Cao","year":"2023","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124449_bib27","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.7150\/ijbs.44343","article-title":"A new SIRT1 inhibitor, MHY2245, induces autophagy and inhibits energy metabolism via PKM2\/mTOR pathway in human ovarian cancer cells","volume":"16","author":"Tae","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.biomaterials.2026.124449_bib28","doi-asserted-by":"crossref","first-page":"5907","DOI":"10.1038\/s41467-022-33599-w","article-title":"Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer","volume":"13","author":"Kennedy","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124449_bib29","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1021\/acs.nanolett.2c00699","article-title":"Boarding oncolytic viruses onto tumor-homing bacterium-vessels for augmented cancer immunotherapy","volume":"22","author":"Sun","year":"2022","journal-title":"Nano Lett."},{"key":"10.1016\/j.biomaterials.2026.124449_bib30","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj0624","article-title":"Genome-editing prodrug: targeted delivery and conditional stabilization of CRISPR-Cas9 for precision therapy of inflammatory disease","volume":"7","author":"Yan","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2026.124449_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz6667","article-title":"Combination of metabolic intervention and T cell therapy enhances solid tumor immunotherapy","volume":"12","author":"Hao","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124449_bib32","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4161\/auto.6.7.13075","article-title":"Synthetic substrates for measuring activity of autophagy proteases: autophagins (Atg4)","volume":"6","author":"Shu","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.biomaterials.2026.124449_bib33","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1021\/acsnano.6b07843","article-title":"An in situ intracellular self-assembly strategy for quantitatively and temporally monitoring autophagy","volume":"11","author":"Lin","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124449_bib34","article-title":"On-Demand autophagy Cascade amplification nanoparticles precisely enhanced oxaliplatin-induced cancer immunotherapy","volume":"32","author":"Wang","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124449_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1126\/science.1126766","article-title":"Aggresomes and autophagy generate sites for virus replication","volume":"312","author":"Wileman","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.biomaterials.2026.124449_bib36","doi-asserted-by":"crossref","first-page":"18282","DOI":"10.1021\/acsnano.4c01115","article-title":"Enhancing the antitumor efficacy of oncolytic adenovirus through sonodynamic therapy-augmented virus replication","volume":"18","author":"Ding","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124449_bib37","doi-asserted-by":"crossref","first-page":"14461","DOI":"10.1021\/acsnano.3c00847","article-title":"Virus-protein Corona replacement strategy to improve the antitumor efficacy of intravenously injected oncolytic adenovirus","volume":"17","author":"Huang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124449_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202370197","article-title":"Inhibition of tumor metastasis by liquid-nitrogen-shocked tumor cells with oncolytic viruses infection","volume":"35","author":"Wu","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2026.124449_bib39","article-title":"Tumor cell membrane-based vaccines: a potential boost for cancer immunotherapy","volume":"4","author":"Yang","year":"2024","journal-title":"Explorations"},{"key":"10.1016\/j.biomaterials.2026.124449_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/VIW.20200027","article-title":"Bionanoparticles in cancer imaging, diagnosis, and treatment","volume":"3","author":"Li","year":"2022","journal-title":"View"},{"key":"10.1016\/j.biomaterials.2026.124449_bib41","article-title":"Biomimetic and bioinspired nano-platforms for cancer vaccine development","volume":"3","author":"Feng","year":"2023","journal-title":"Explorations"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226004734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:47:10Z","timestamp":1787777230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226004734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":41,"alternative-id":["S0142961226004734"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124449","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic virus-drug conjugates for increased viral replication efficiency and potentiated cancer chemoimmunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124449","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124449"}}